Toward Precision Medicine-Is Genetic Risk Prediction Ready for Prime Time in Osteoarthritis?
Arthritis Rheumatol
.
2022 Sep;74(9):1477-1479.
doi: 10.1002/art.42155.
Epub 2022 Jul 25.
Authors
Michelle S Yau
1
,
John Loughlin
2
Affiliations
1
Harvard Medical School, Boston, Massachusetts.
2
Newcastle University and International Centre for Life, Newcastle-upon-Tyne, UK.
PMID:
35522793
PMCID:
PMC9427682
DOI:
10.1002/art.42155
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Humans
Osteoarthritis* / genetics
Precision Medicine*
Risk Factors
Grants and funding
R01 AR075356/AR/NIAMS NIH HHS/United States
MR/P020941/1/MRC_/Medical Research Council/United Kingdom
P30 AR072571/AR/NIAMS NIH HHS/United States